Abstract:Background and purpose: Gene chip is a nucleic acid sequence analysis method which is based on hybridization. It is a high-through put assay which can widely detect the level of gene expression in different tissues and cell types. This study aimed to compare and bioinformatically analyze differentially expressed genes between higher malignant degree of prostate cancer tissues and prostate inflammation tissues. Methods: The total RNAs were isolated from tissues of prostate cancer and prostate inflammation by TRIzol method and then purified, reversely tran-scribed to cDNA with incorporating biotin labeling probe, hybridized with Affymetrix Human U133 Plus 2.0 (covering 47000 transcripts,representing 38500 distinct genes). Picture signals of fluorescence in gene array were scanned and differential expression of gene in two tissues were compared by Command Console Software 4.0. These differential expressed genes were analyzed by bioinformatics methods finally. Results: According to the fold change ≥2, P<0.05, 1819 differential expression genes including 1025 up-regulated genes and 794 down-regulated genes were discovered. GO enrichment analysis displayed that these differentially expressed genes were mainly involved in cell cycle, cell metabolism, etc. KEGG pathway analysis found that these genes were mainly involved in some metabolism pathways including purine nucleotide metabolism. The interactions between the proteins encoded by these genes were analyzed by STING. Twenty key nodes genes including TPX2, ANLN, NUSAP1, MELK, DLGAP5, KIF11, TOP2A, RRM2 were dis-covered. Then this study revealed CEP55 and ANLN might be related to the occurrence and metastasis of prostate cancer by looking through literature. Conclusion: During the development of prostate cancer, the activation of genes related to cell cycle and cell migration, the abnormalities of genes related to metabolism and the inhibition of genes related to cell adhesion play critical roles in the development of prostate cancer. CEP55 and ANLN were related to the occurrence and prognosis of prostate cancer by systematic analysis which provided a valuable clue for the next experiment.

Microarray analysis of tumor metastasis-related genes in LNCaP/PC-3 prostate cancer progression model

Differential Metastasis-Associated Gene Analysis of Prostate Carcinoma Cells Derived from Primary Tumor and Spontaneous Lymphatic Metastasis in Nude Mice with Orthotopic Implantation of Pc-3m Cells

Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.

Investigation of the Molecular Mechanisms Underlying Metastasis in Prostate Cancer by Gene Expression Profiling

Screening for differential genes of the prostate cancer and bioinformatics analysis of their interaction

Analysis of differentially expressed genes between the high-metastatic and low-metastatic lung cancer cell lines

Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in Association with Metastasis Risk and Progression of Prostate Cancer

Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis

Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis

Preliminary Screening and Analysis of Metastasis-Related Lncrna and Co-Expressed Papillary Thyroid Carcinoma Mrna.

Screening of Differentially Expressed Genes of Prostate Cancer with DNA Microarray

MicroRNA Alteration Associated with Prostate Cancer LNCaP Cell Progression to Androgen-Independence

Comprehensive transcriptomic analysis of prostate cancer lung metastases

Microarray Analyses Reveal Liver Metastasis-Related Genes in Metastatic Colorectal Cancer Cell Model.

Identification of Key Gene Signatures Associated With Bone Metastasis in Castration-Resistant Prostate Cancer Using Co-Expression Analysis

Comparative Proteomics Uncovers Correlated Signaling Network and Potential Biomarkers for Progression of Prostate Cancer

Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model

Proteomic Comparison and MRM-Based Comparative Analysis of Metabolites Reveal Metabolic Shift in Human Prostate Cancer Cell Lines

An Extensive Study of the Mechanism of Prostate Cancer Metastasis.

Quantitative Proteomic Study of Human Prostate Cancer Cells with Different Metastatic Potentials.

Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma.